Mon, November 13, 2023
Sun, November 12, 2023
Fri, November 10, 2023
Thu, November 9, 2023

Serge Belanger Maintained (VRCA) at Strong Buy with Decreased Target to $8 on, Nov 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-8-on-nov-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $10 to $8 on, Nov 10th, 2023.

Serge has made no other calls on VRCA in the last 4 months.



There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Serge's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Serge


  • Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Thursday, October 12th, 2023
  • Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $14 on, Tuesday, July 25th, 2023

Publication Contributing Sources